Based on these results and previous experiments, we concluded that overactivated NRF2 may affect the sensitivity of esophageal cancer cells to radiotherapy by regulating the expression of GPX4 through GCLM (Figure 5A). This evidence concerns the gene GPX4 and esophageal cancer.